Biotech Values

[mcbio]

Well MDV3100 in early stage trials (at a higher dose) had a couple of seizures reported as SAEs.

Do you know how much higher that dose was that caused the seizures than what was used in Phase 3? Just curious if we are talking something on the order of double or more or if it's a much narrower difference in dose.